Analysts Offer Insights on Healthcare Companies: Shattuck Labs (STTK) and Verastem (VSTM)
TipRanksApr 12 07:00 ET
Analysts Conflicted on These Healthcare Names: Shattuck Labs (STTK), Johnson & Johnson (JNJ) and Tilray (TLRY)
TipRanksApr 10 12:10 ET
Strong Buy Rating for Shattuck Labs on Innovative Immunotherapy Pipeline and Leadership
TipRanksApr 9 06:16 ET
Shattuck Labs Analyst Ratings
BenzingaApr 9 06:16 ET
Shattuck Labs Analyst Ratings
BenzingaMar 1 06:51 ET
Buy Rating Affirmed for Shattuck Labs on Strong Financials and Promising Clinical Trials
TipRanksMar 1 06:18 ET
Shattuck Labs (STTK) Receives a Buy From TD Cowen
TipRanksFeb 29 21:46 ET
Buy Rating Affirmed: Shattuck Labs' Promising Partnerships and Clinical Advancements
TipRanksFeb 14 06:37 ET
Shattuck Labs Analyst Ratings
BenzingaFeb 13 09:36 ET
Analysts Offer Insights on Healthcare Companies: Haemonetics (HAE) and Shattuck Labs (STTK)
TipRanksFeb 13 09:20 ET
Buy Rating Affirmed for Shattuck Labs on Promising Clinical Results and Strong Financial Footing
TipRanksJan 9 06:33 ET
BTIG Reaffirms Their Buy Rating on Shattuck Labs (STTK)
TipRanksJan 2 09:48 ET
Shattuck Labs (STTK) Gets a Buy From BTIG
TipRanksDec 31, 2023 05:24 ET
Analysts Offer Insights on Healthcare Companies: Athira Pharma (ATHA), Shattuck Labs (STTK) and Matinas BioPharma (MTNB)
TipRanksNov 10, 2023 05:50 ET
Analysts Offer Insights on Healthcare Companies: PDS Biotechnology (PDSB) and Shattuck Labs (STTK)
TipRanksNov 9, 2023 10:21 ET
Shattuck Labs Earns Buy Rating: Promising Trial Results and Solid Financial Health
TipRanksNov 9, 2023 09:06 ET
Promising Early Clinical Results Support Buy Rating on Shattuck Labs: An In-depth Analysis of SL-172154's Potential
TipRanksNov 2, 2023 15:47 ET
Promising Clinical Trials and Dual-Action Mechanism Propel Shattuck Labs to a Buy Rating: An Analysis by H.C. Wainwright
TipRanksNov 2, 2023 12:33 ET
Berenberg Bank Sticks to Its Buy Rating for Shattuck Labs (STTK)
TipRanksOct 25, 2023 21:56 ET
Berenberg Bank Adjusts Shattuck Labs Price Target to $4 From $20, Maintains Buy Rating
MT NewswiresSep 15, 2023 08:24 ET
No Data
No Data